228 filings
Page 5 of 12
SC 13G/A
SQZB
SQZ Biotechnologies Co
14 Feb 22
SQZ Biotechnologies / AMERICAN INTERNATIONAL ownership change
3:51pm
SC 13G/A
SQZB
SQZ Biotechnologies Co
14 Feb 22
SQZ Biotechnologies / Temasek Holdings ownership change
6:32am
SC 13G/A
683 Capital Management, LLC
14 Feb 22
SQZ Biotechnologies / 683 Capital Management ownership change
12:00am
SC 13D/A
Management Co. VII, L.L.C. Polaris
11 Feb 22
SQZ Biotechnologies / Polaris Management Co. VII, L.L.C. ownership change
5:12pm
SC 13G/A
NanoDimension II Management Ltd
10 Feb 22
SQZ Biotechnologies / NanoDimension II Management ownership change
4:08pm
SC 13G/A
SQZB
SQZ Biotechnologies Co
9 Feb 22
SQZ Biotechnologies / BlackRock ownership change
5:22pm
SC 13G
BLK
Blackrock Inc.
4 Feb 22
SQZ Biotechnologies / BlackRock ownership change
4:12pm
8-K
SQZB
SQZ Biotechnologies Co
24 Jan 22
SQZ Biotechnologies Announces FDA Clearance of Investigational New Drug (IND) Application for SQZ-eAPC-HPV, a Novel mRNA-based Cell Therapy for the Treatment of HPV16 Positive Solid Tumors
7:01am
4
Armon Sharei
13 Jan 22
SQZ Biotechnologies / Armon Sharei ownership change
5:15pm
4
SQZB
SQZ Biotechnologies Co
4 Jan 22
SQZ Biotechnologies / Armon Sharei ownership change
5:15pm
4
Lawrence J Knopf
4 Jan 22
SQZ Biotechnologies / Lawrence J Knopf ownership change
5:15pm
4
Schulman Amy W
23 Dec 21
SQZ Biotechnologies / AMY W SCHULMAN ownership change
5:15pm
4
SQZB
SQZ Biotechnologies Co
22 Dec 21
SQZ Biotechnologies / Armon Sharei ownership change
5:15pm
4
SQZB
SQZ Biotechnologies Co
15 Dec 21
SQZ Biotechnologies / AMY W SCHULMAN ownership change
5:15pm
8-K
SQZB
SQZ Biotechnologies Co
9 Dec 21
Other Events
7:30am
8-K
SQZB
SQZ Biotechnologies Co
2 Dec 21
Other Events
6:28am
EFFECT
SQZB
SQZ Biotechnologies Co
19 Nov 21
Notice of effectiveness
12:15am
8-K/A
SQZB
SQZ Biotechnologies Co
18 Nov 21
Departure of Directors or Certain Officers
5:03pm
3
SQZB
SQZ Biotechnologies Co
16 Nov 21
SQZ Biotechnologies / Richard Capasso ownership change
4:50pm
CORRESP
SQZB
SQZ Biotechnologies Co
16 Nov 21
Correspondence with SEC
12:00am